Table 1. Baseline Characteristics of the Study Participantsa.
| Characteristic | Xuesaitong group (n = 1487) | Control group (n = 1479) |
|---|---|---|
| Age, median (IQR), y | 62 (55-68) | 62 (55-68) |
| Sex | ||
| Male | 957 (64.4) | 1025 (69.3) |
| Female | 530 (35.6) | 454 (30.7) |
| BMI, median (IQR) | 24.5 (22.6-26.6) | 24.5 (22.5-26.6) |
| Heart rate, median (IQR) | 75 (69-80) | 76 (69-80) |
| SBP, median (IQR), mm Hg | 142 (132-156) | 141 (132-157) |
| DBP, median (IQR), mm Hg | 84 (78-92) | 85 (78-93) |
| NIHSS score, median (IQR) | 5 (4-7) | 5 (4-7) |
| EQ-5D score, median (IQR) | 75 (60-86) | 75 (60-90) |
| Barthel Index, median (IQR) | 75 (55-90) | 75 (55-90) |
| Intravenous thrombolysis | 140 (9.4) | 123 (8.3) |
| Mechanical thrombectomy | 12 (0.8) | 6 (0.4) |
| Medical and personal history | ||
| Hypertension | 835 (56.2) | 821 (55.5) |
| Diabetes | 356 (23.9) | 361 (24.4) |
| Hyperlipidemia | 73 (4.9) | 79 (5.3) |
| Current smoking | 356 (23.9) | 385 (26.0) |
| Current drinking | 191 (12.8) | 181 (12.2) |
| Laboratory test results, median (IQR) | ||
| Glucose, mg/dL | 102.70 (90.09-136.94) | 104.50 (90.09-135.14) |
| Total cholesterol, mg/dL | 173.75 (146.72-200.77) | 173.75 (146.72-200.77) |
| Fibrinogen, mg/dL | 98.64 (81.63-115.65) | 98.64 (81.63-115.65) |
| Platelet counts, ×103/μL | 212 (173-252) | 211 (173-250) |
| PT, s | 11.2 (10.5-12.3) | 11.3 (10.5-12.3) |
| APTT, s | 28.1 (24.5-32.4) | 28.0 (24.5-32.3) |
| TOAST classification | ||
| Large artery atherosclerosis | 789 (53.1) | 788 (53.3) |
| Cardioembolism | 15 (1.0) | 21 (1.4) |
| Small vessel occlusion | 618 (41.6) | 611 (41.3) |
| Other determined cause | 23 (1.5) | 16 (1.1) |
| Undetermined cause | 42 (2.8) | 43 (2.9) |
Abbreviations: APTT, activated partial thromboplastin time; BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); DBP, diastolic blood pressure; EQ-5D, EuroQoL Group 5-Dimension; NIHSS, National Institutes of Health Stroke Scale; PT, prothrombin time; TOAST, Trial of Org 10172 in Acute Stroke Treatment; SBP, systolic blood pressure.
SI conversion factors: To convert glucose to millimoles per liter, multiply by 0.0555; total cholesterol to millimoles per liter, multiply by 0.0259; fibrinogen to grams per liter, multiply by 0.01; and platelet counts to ×109/L, multiply by 1.
a
Data are presented as number (percentage) of patients unless otherwise indicated.